Plamotamab (XmAb®13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia

  • Leuk Lymphoma. 2022 Mar;63(3):738-742. doi: 10.1080/10428194.2021.2005045.
Ricardo D Parrondo  1 ,  Aneel Paulus  1 ,  Victoria Alegria  1 ,  David Liebowitz  2 ,  Chelsea Johnson  2 ,  Raphael Clynes  2 ,  Vivek Roy  1 ,  David M Menke  3 ,  Liuyan Jiang  3 ,  Asher A Chanan-Khan  1 ,  Sikander Ailawadhi  1
Affiliations
  • 1. Deparment of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
  • 2. Xencor, Inc, Monrovia, CA, USA.
  • 3. Department of Pathology, Mayo Clinic Florida, Jacksonville, FL, USA.
PMID: 34781809 DOI: 10.1080/10428194.2021.2005045
Products